Impact of the COVID‐19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study
Worry
Depression
DOI:
10.1111/dme.14611
Publication Date:
2021-05-30T10:20:26Z
AUTHORS (11)
ABSTRACT
To examine psychosocial and behavioural impacts of the novel coronavirus disease 2019 (COVID-19) pandemic lockdown restrictions among adults with type 2 diabetes.Participants enrolled in PRogrEssion DIabetic ComplicaTions (PREDICT) cohort study Melbourne, Australia (n = 489 a baseline assessment pre-2020) were invited to complete phone/online follow-up mid-2020 (i.e., amidst COVID-19 restrictions). Repeated assessments that compared pre-COVID-19 levels included anxiety symptoms (7-item Generalised Anxiety Disorder scale [GAD-7]), depressive (8-item Patient Health Questionnaire [PHQ-8]), diabetes distress (Problem Areas Diabetes [PAID]), physical activity/sedentary behaviour, alcohol consumption self-management behaviours. Additional once-off measures at COVID-19-specific worry, quality life (QoL), healthcare appointment changes (telehealth engagement cancellations/avoidance).Among 470 respondents (96%; aged 66 ± 9 years, 69% men), least 'moderate' worry about infection was reported by 31%, 29%-73% negative on QoL dimensions (greatest for: leisure activities, feelings future, emotional well-being). Younger participants more (p < 0.05). Overall, anxiety/depressive similar pre-COVID-19, but reduced 0.001). Worse trajectories observed those who or Physical activity trended lower (~10%), sitting time, glucose-monitoring frequency remained unchanged. 73% used telehealth, 43% cancelled 39% avoided new appointments despite perceived need.COVID-19 negatively impacted QoL, some risk factors utilisation diabetes. However, generalised relatively stable.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (39)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....